EUVIMEDEUVIMED entdecken
Open Access

PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure

Ming-Sum Lee, James Onwuzurike, Yi-Lin Wu, Darryl E Palmer-Toy, Jaejin An, Wansu Chen

JAMA Network Open · 16.09.2025 · 8 (9) · e2532164

DOI: 10.1001/jamanetworkopen.2025.32164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 16.09.2025. Verfasst von Ming-Sum Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The Predicting Risk of Cardiovascular Disease Events (PREVENT) equations are an updated model developed to improve on the Pooled Cohort Equation (PCE) for estimating 10-year atherosclerotic cardiovascular disease (ASCVD) risk. These equations facilitate patient-clinician discussions on initiating statin therapy and are used to estimate risk without treatment. However, statin exposure during follow-up was not fully accounted for in the development of these equations.

Objective

To assess the performance of the PCE and PREVENT equations in estimating ASCVD, accounting for statin exposure during follow-up. Design, Setting, and Participants This retrospective cohort study included adults from an integrated health care system with 10-year follow-up data. Adults without diabetes or ASCVD were identified in 2013 and followed-up through December 31, 2023, with analyses performed in January 2025. Main Outcomes and Measures The primary outcome was incident ASCVD. Estimated risks from PCE and PREVENT equations were compared with observed risks, with discrimination assessed via C statistics. The performance of these equations was evaluated in patient populations stratified by statin exposure during follow-up.

Results

Among 193 885 adults (median [IQR] age, 55 [48-63] years; 113 400 [58.5%] women), 6528 experienced an ASCVD event. The C statistic was 0.725 (95% CI, 0.719-0.731) for PCE and 0.723 (95% CI, 0.716-0.729) for PREVENT. In the overall population, regardless of statin exposure, the observed 10-year ASCVD risk was lower than estimated by PCE: 3.6% for individuals with estimated risk of 5% to less than 7.5%, 4.5% for those with estimated risk of 7.5% to less than 10%, and 8.0% for those with estimated risk of 10% or greater. The observed risk more closely aligned with the estimated risk from PREVENT: 5.2% for individuals with estimated risk of 5% to 7.5%, 8.1% for those with estimated risk 7.5% to less than 10%, and 11.6% for those with estimated risk of 10% or greater. In contrast, among patients not exposed to statin therapy during follow-up, PREVENT underestimated risk: observed risk was 8.2% for individuals with estimated risk of 5% to less than 7.5%, and 13.5% for those with estimated risk of 7.5% to less than 10%, while PCE-estimated risk more closely approximated the observed risk. Conclusions and Relevance In this retrospective cohort study, the PREVENT model underestimated risk in patients not treated with statins, whereas the PCE estimates more closely reflected what a patient’s risk would be without statin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsAtherosclerosisHumansFemaleMiddle AgedMaleRetrospective StudiesRisk AssessmentAgedRisk Factors

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
  • SCPMG Regional Reference Laboratories, Kaiser Permanente Southern California, North Hollywood.

Zitieren

APA

Lee, M. S., Onwuzurike, J., Wu, Y. L., Palmer-Toy, D. E., An, J., & Chen, W. (2025). PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure. JAMA Network Open, 8(9), e2532164. https://doi.org/10.1001/jamanetworkopen.2025.32164

Vancouver

Lee MS, Onwuzurike J, Wu YL, Palmer-Toy DE, An J, Chen W. PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure. JAMA Network Open. 2025;8(9):e2532164. doi:10.1001/jamanetworkopen.2025.32164

BibTeX
@article{Lee2025,
  author = {Lee, Ming-Sum and Onwuzurike, James and Wu, Yi-Lin and Palmer-Toy, Darryl E and An, Jaejin and Chen, Wansu},
  title = {PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {9},
  pages = {e2532164},
  doi = {10.1001/jamanetworkopen.2025.32164}
}
Kostenlos starten →